Key facts
- SQK’s last known valuation is $7.0M (Jan 2026).
- It has raised $750K; the latest was Early Stage VC ($500K) in Jan 2026.
- Notable investors include QAI Ventures, ACET, Duality Accelerator, IBM Ventures, K-Startup Center Seattle.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for SQK
- ·The full record, as it builds
Funding rounds
No funding rounds for SQK are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SQK
Developer of a medical imaging platform designed to enhance the accuracy and reliability of diagnostic image reconstruction. The company offers physics-constrained modeling, quantum-enhanced reconstruction, and model refinement capabilities, enabling healthcare providers and medical AI developers to improve diagnostic confidence and support safer imaging practices.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2023
- Employees
- 12
- Website
- sqkcloud.com/
- Ownership
- Privately Held (backing)
SQK doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SQK shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SQK in its N-PORT filings yet. We sweep new filings monthly.